The ad said a starter price. Month two said something else.
We believe you.
People looking up GLP-1 telehealth hidden fees are usually holding two numbers that should have been one. A membership sitting on top of the drug. Or a first-month teaser that died the day the dose went up.
The complaint is common enough that it has a shape. A cheap intro price on the first screen. Then a membership fee sitting on top of the drug on later statements. Or a charge that climbs the month the dose goes up. Sometimes the same charge lands twice. And cancelling turns out to be harder than signing up was.
None of that is an accident. It is how a program can be built. Once you know where the extra lines come from, the second-month number stops being a surprise.
We believe you.
How GLP-1 telehealth hidden fees show up
Some programs sell a start price and then bill a membership as a second product. The drug is its own line. The membership is the right to keep getting it. Miss the cancel window and the card runs again.
Some programs price the vial by how many milligrams you are on. That matters because these medicines are not meant to stay at the first dose.
Wegovy injection starts at 0.25 mg once a week for four weeks, then steps up every four weeks. The usual maintenance dose is 2.4 mg. Zepbound starts at 2.5 mg once a week for four weeks. That 2.5 mg amount is for getting started. It is not approved as a maintenance dose. Later maintenance is 5 mg, 10 mg, or 15 mg.
If the program’s drug line tracks the milligrams, the second month can cost more even if nobody changed the plan. A clinician may hold a step because of nausea. The statement may not.
The FTC has a name for quoting a low price and then adding mandatory charges after you have already spent time trying to buy. Drip pricing. The 2024 junk-fees rule pointed that practice at tickets and short-term stays. The Commission still said the same bait shows up across the economy. Ordinary consumer-protection law already covers deception about price.
Online recurring charges have their own rule. Before a seller takes billing information, federal law requires a clear display of the material terms. Express consent before the charge. A simple way to stop later charges.
None of that writes the number on your statement. You still have to look.
Ask what month two costs with every fee on the same line as the drug.
What you are actually paying each month
At Living+ compounded semaglutide is 197 dollars a month and compounded tirzepatide is 247, flat. Each month includes a personal coach. There is no separate visit fee. The price does not rise with the dose. If a clinician declines you, the charge is refunded.
Compounded copies are not FDA-approved Wegovy or Zepbound. FDA does not verify the safety, effectiveness, or quality of a compounded drug before it is marketed. Some people still do not lose much. Talk to your provider before you save a card on a start price you have not added up.
Prices were accurate at the time this was published.
Sources
- FDA: Compounding and the FDA, compounded drugs are not FDA-approved
- DailyMed: Wegovy (semaglutide) starting dose 0.25 mg, titration, usual maintenance 2.4 mg
- FDA: Wegovy (semaglutide) prescribing information, dosage and administration
- DailyMed: Zepbound (tirzepatide) 2.5 mg is for treatment initiation and is not approved as a maintenance dosage
- FDA: Zepbound (tirzepatide) prescribing information, starting dose and maintenance doses
- 15 U.S.C. 8403: ROSCA negative option marketing on the Internet, disclose terms, consent, simple stop
- Public Law 111-345: Restore Online Shoppers' Confidence Act
- Federal Register: Trade Regulation Rule on Unfair or Deceptive Fees, drip pricing defined
See what a Living+ plan costs and whether it fits.
